Flu Vaccines

Vaxine Makes Unsolicited Bid to Acquire U.S. Company Protein Sciences Corporation

Published in Vaccine Weekly, November 12th, 2008

Vaxine Pty Ltd announced that it made an unsolicited bid to acquire Protein Sciences Corporation, a privately-held vaccine company located in Meriden, Connecticut USA. The terms of the proposed offer were not disclosed but include a stock for stock exchange and the assumption of liabilities with a potential total deal value in excess of U.S. $60 million.

Nikolai Petrovsky, Chairman of Vaxine, said, "We have been following Protein Sciences for some time and are impressed with its vaccine products and patented cell line and rapid progress in bringing their influenza vaccines through the U.S. regulatory process. He added, "We already are a major collaborator under Protein...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2008-11-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry